COVID-19 and the liver: What do we know after six months of the pandemic?

doi:10.1016/j.aohep.2020.09.001

. 2020 Nov-Dec;19(6):590-591.

doi: 10.1016/j.aohep.2020.09.001. Epub 2020 Sep 18.

COVID-19 and the liver: What do we know after six months of the pandemic?

Nora A Fierro¹

Affiliations

Affiliation

¹ Department of Immunology, Biomedical Research Institute, National Autonomous University of Mexico, Mexico. Electronic address: noraalma@iibiomedicas.unam.mx.

PMID: 32956871
PMCID: PMC7500273
DOI: 10.1016/j.aohep.2020.09.001

COVID-19 and the liver: What do we know after six months of the pandemic?

Nora A Fierro. Ann Hepatol. 2020 Nov-Dec.

. 2020 Nov-Dec;19(6):590-591.

doi: 10.1016/j.aohep.2020.09.001. Epub 2020 Sep 18.

Author

Nora A Fierro¹

Affiliation

¹ Department of Immunology, Biomedical Research Institute, National Autonomous University of Mexico, Mexico. Electronic address: noraalma@iibiomedicas.unam.mx.

PMID: 32956871
PMCID: PMC7500273
DOI: 10.1016/j.aohep.2020.09.001

Abstract

Despite liver injury in patients infected with severe acute respiratory syndrome (SARS) coronavirus (CoV)-2 (SARS-CoV-2) is associated with prolonged hospitalization, and liver dysfunction is mainly described in patients with severe viral disease. How liver abnormalities may affect virus infection is still unknown. Improved understanding of host genetics, lifestyle, underlying comorbidities and adequate follow-up of patients with liver damage are critical in the new scenario of the pandemic virus.

Keywords: COVID-19 comorbidities; COVID-19 symptoms; Liver disease; SARS.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest to declare.

Cited by

It Can't Be a Coincidence: A Comparison of Cases of Autoimmune Hepatitis After Vaccination Against COVID-19.
Gips JR, Woreta TA. Gips JR, et al. ACG Case Rep J. 2023 Feb 1;10(1):e00965. doi: 10.14309/crj.0000000000000965. eCollection 2023 Jan. ACG Case Rep J. 2023. PMID: 36743330 Free PMC article.
COVID-19: Gastrointestinal manifestations, liver injury and recommendations.
Ozkurt Z, Çınar Tanrıverdi E. Ozkurt Z, et al. World J Clin Cases. 2022 Feb 6;10(4):1140-1163. doi: 10.12998/wjcc.v10.i4.1140. World J Clin Cases. 2022. PMID: 35211548 Free PMC article. Review.
Liver injury in the era of COVID-19.
Cichoż-Lach H, Michalak A. Cichoż-Lach H, et al. World J Gastroenterol. 2021 Feb 7;27(5):377-390. doi: 10.3748/wjg.v27.i5.377. World J Gastroenterol. 2021. PMID: 33584070 Free PMC article. Review.
COVID-19, Possible Hepatic Pathways and Alcohol Abuse-What Do We Know up to 2023?
Michalak A, Lach T, Szczygieł K, Cichoż-Lach H. Michalak A, et al. Int J Mol Sci. 2024 Feb 12;25(4):2212. doi: 10.3390/ijms25042212. Int J Mol Sci. 2024. PMID: 38396888 Free PMC article. Review.
Profiling metabolites and lipoproteins in COMETA, an Italian cohort of COVID-19 patients.
Ghini V, Meoni G, Pelagatti L, Celli T, Veneziani F, Petrucci F, Vannucchi V, Bertini L, Luchinat C, Landini G, Turano P. Ghini V, et al. PLoS Pathog. 2022 Apr 21;18(4):e1010443. doi: 10.1371/journal.ppat.1010443. eCollection 2022 Apr. PLoS Pathog. 2022. PMID: 35446921 Free PMC article.

See all "Cited by" articles

References

1. Gavriatopoulou M., Korompoki E., Fotiou D., Ntanasis-Stathopoulos I., Psaltopoulou T., Kastritis E., et al. Organ-specific manifestations of COVID-19 infection. Clin Exp Med. 2020;27:1–14. doi: 10.1007/s10238-020-00648-x. - DOI - PMC - PubMed
1. Grant M.C., Geoghegan L., Arbyn M., Mohammed Z., McGuiness L., Clarke E.L., et al. The prevalence of symptoms in 24,410 adults infected by the novel coronavirus (SARS-CoV-2; COVID-19): a systemic review and meta-analysis of 148 studies from 9 countries. PLoS One. 2020;15 doi: 10.1371/journal.pone.0234765. - DOI - PMC - PubMed
1. Zhang C., Shi L., Wang F.S. Liver injury in COVID-19: management and challenges. Lancet Gastroenterol Hepatol. 2020;5:428–430. doi: 10.1016/S2468-1253(20)30057-1. - DOI - PMC - PubMed
1. Wong Y.J., Tan M., Zheng Q., Li W., Kumar R., Fock K.M., et al. A systemic review and meta-analysis of the COVID-19 associated liver injury. Ann Hepatol. 2020 in press. - PMC - PubMed
1. Ridruejo E., Soza A. The liver in times of COVID-19: what hepatologists should know. Ann Hepatol. 2020;19:353–358. doi: 10.1016/j.aohep.2020.05.001. - DOI - PMC - PubMed

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information
Miscellaneous
- NCI CPTAC Assay Portal

[1] Gavriatopoulou M., Korompoki E., Fotiou D., Ntanasis-Stathopoulos I., Psaltopoulou T., Kastritis E., et al. Organ-specific manifestations of COVID-19 infection. Clin Exp Med. 2020;27:1–14. doi: 10.1007/s10238-020-00648-x. - DOI - PMC - PubMed

[2] Gavriatopoulou M., Korompoki E., Fotiou D., Ntanasis-Stathopoulos I., Psaltopoulou T., Kastritis E., et al. Organ-specific manifestations of COVID-19 infection. Clin Exp Med. 2020;27:1–14. doi: 10.1007/s10238-020-00648-x. - DOI - PMC - PubMed

[3] Grant M.C., Geoghegan L., Arbyn M., Mohammed Z., McGuiness L., Clarke E.L., et al. The prevalence of symptoms in 24,410 adults infected by the novel coronavirus (SARS-CoV-2; COVID-19): a systemic review and meta-analysis of 148 studies from 9 countries. PLoS One. 2020;15 doi: 10.1371/journal.pone.0234765. - DOI - PMC - PubMed

[4] Grant M.C., Geoghegan L., Arbyn M., Mohammed Z., McGuiness L., Clarke E.L., et al. The prevalence of symptoms in 24,410 adults infected by the novel coronavirus (SARS-CoV-2; COVID-19): a systemic review and meta-analysis of 148 studies from 9 countries. PLoS One. 2020;15 doi: 10.1371/journal.pone.0234765. - DOI - PMC - PubMed

[5] Zhang C., Shi L., Wang F.S. Liver injury in COVID-19: management and challenges. Lancet Gastroenterol Hepatol. 2020;5:428–430. doi: 10.1016/S2468-1253(20)30057-1. - DOI - PMC - PubMed

[6] Zhang C., Shi L., Wang F.S. Liver injury in COVID-19: management and challenges. Lancet Gastroenterol Hepatol. 2020;5:428–430. doi: 10.1016/S2468-1253(20)30057-1. - DOI - PMC - PubMed

[7] Wong Y.J., Tan M., Zheng Q., Li W., Kumar R., Fock K.M., et al. A systemic review and meta-analysis of the COVID-19 associated liver injury. Ann Hepatol. 2020 in press. - PMC - PubMed

[8] Wong Y.J., Tan M., Zheng Q., Li W., Kumar R., Fock K.M., et al. A systemic review and meta-analysis of the COVID-19 associated liver injury. Ann Hepatol. 2020 in press. - PMC - PubMed

[9] Ridruejo E., Soza A. The liver in times of COVID-19: what hepatologists should know. Ann Hepatol. 2020;19:353–358. doi: 10.1016/j.aohep.2020.05.001. - DOI - PMC - PubMed

[10] Ridruejo E., Soza A. The liver in times of COVID-19: what hepatologists should know. Ann Hepatol. 2020;19:353–358. doi: 10.1016/j.aohep.2020.05.001. - DOI - PMC - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

COVID-19 and the liver: What do we know after six months of the pandemic?

Affiliation

COVID-19 and the liver: What do we know after six months of the pandemic?

Author

Affiliation

Abstract

Conflict of interest statement

Similar articles

Cited by

References

MeSH terms

LinkOut - more resources

Full Text Sources

Medical

Miscellaneous